{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:40:33Z","timestamp":1790016033307,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56 AI099275"],"award-info":[{"award-number":["R56 AI099275"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RO1 AI080598"],"award-info":[{"award-number":["RO1 AI080598"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009024","name":"Exploratory Research for Advanced Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.coviro.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,9,13]],"date-time":"2015-09-13T20:30:22Z","timestamp":1442176222000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Influenza virus\u2013host interactomes as a basis for antiviral drug development"],"prefix":"10.1016","volume":"14","author":[{"given":"Tokiko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2015.08.008_bib0435","series-title":"Fields Virology","first-page":"1186","article-title":"Orthomyxoviruses","author":"Wright","year":"2013"},{"key":"10.1016\/j.coviro.2015.08.008_bib0440","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.08.008_bib0445","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1304617","article-title":"Epidemiology of human infections with avian influenza A(H7N9) virus in China","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.08.008_bib0450","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMp068205","article-title":"H5N1 influenza-continuing evolution and spread","volume":"355","author":"Webster","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.08.008_bib0455","first-page":"3","article-title":"Pandemic influenza as a current threat","volume":"333","author":"Yen","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0460","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-adamantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.08.008_bib0465","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1098\/rstb.2001.1007","article-title":"Perspectives on antiviral use during pandemic influenza","volume":"356","author":"Hayden","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.coviro.2015.08.008_bib0470","first-page":"187","article-title":"Influenza treatment and prophylaxis with neuraminidase inhibitors: a review","volume":"6","author":"Kamali","year":"2013","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.coviro.2015.08.008_bib0475","doi-asserted-by":"crossref","first-page":"e1000786","DOI":"10.1371\/journal.ppat.1000786","article-title":"Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses","volume":"6","author":"Kiso","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.08.008_bib0480","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMp0910479","article-title":"The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza","volume":"361","author":"Birnkrant","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.08.008_bib0485","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/cid\/cir001","article-title":"Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States","volume":"52","author":"Hernandez","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2015.08.008_bib0490","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2015.08.008_bib0495","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.08.008_bib0500","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2015.08.008_bib0505","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.08.008_bib0510","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2015.08.008_bib0515","first-page":"13","article-title":"Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications","author":"Nicoll","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coviro.2015.08.008_bib0520","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/589289","article-title":"Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents","volume":"47","author":"MacArthur","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2015.08.008_bib0525","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/rmv.534","article-title":"Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy","volume":"17","author":"Watashi","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0530","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/DDDT.S30946","article-title":"Profile of alisporivir and its potential in the treatment of hepatitis C","volume":"7","author":"Gallay","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.coviro.2015.08.008_bib0535","doi-asserted-by":"crossref","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.08.008_bib0540","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.00389-09","article-title":"DAS181 inhibits H5N1 influenza virus infection of human lung tissues","volume":"53","author":"Chan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2015.08.008_bib0545","doi-asserted-by":"crossref","first-page":"e7838","DOI":"10.1371\/journal.pone.0007838","article-title":"Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2015.08.008_bib0550","doi-asserted-by":"crossref","first-page":"e7788","DOI":"10.1371\/journal.pone.0007788","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2015.08.008_bib0555","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0560","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2012.09.013","article-title":"Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection","volume":"96","author":"Lee","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2015.08.008_bib0565","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2015.08.008_bib0570","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2011.07.014","article-title":"Aprotinin and similar protease inhibitors as drugs against influenza","volume":"92","author":"Zhirnov","year":"2011","journal-title":"Antiviral Res"},{"issue":"Pt 1","key":"10.1016\/j.coviro.2015.08.008_bib0575","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1099\/0022-1317-65-1-191","article-title":"Suppression of influenza virus replication in infected mice by protease inhibitors","volume":"65","author":"Zhirnov","year":"1984","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0580","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.00140-10","article-title":"Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors","volume":"84","author":"Bottcher-Friebertshauser","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0585","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.bmcl.2011.06.033","article-title":"Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT","volume":"21","author":"Sielaff","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2015.08.008_bib0590","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/jm400633d","article-title":"Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin","volume":"57","author":"Gagnon","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2015.08.008_bib0595","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0300-9084(94)90149-X","article-title":"Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones","volume":"76","author":"Garten","year":"1994","journal-title":"Biochimie"},{"key":"10.1016\/j.coviro.2015.08.008_bib0600","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/j.1460-2075.1992.tb05305.x","article-title":"Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease","volume":"11","author":"Stieneke-Grober","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2015.08.008_bib0605","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0610","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2015.08.008_bib0615","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0620","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1258\/jrsm.2010.090441","article-title":"The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis","volume":"103","author":"Eyers","year":"2010","journal-title":"J R Soc Med"},{"key":"10.1016\/j.coviro.2015.08.008_bib0625","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1073\/pnas.0812689106","article-title":"A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection","volume":"106","author":"Marsolais","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.08.008_bib0630","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1107024108","article-title":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.08.008_bib0635","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tips.2011.10.004","article-title":"Emerging cellular targets for influenza antiviral agents","volume":"33","author":"Muller","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coviro.2015.08.008_bib0640","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2015.05.006","article-title":"Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells","volume":"120","author":"Lu","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0645","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature08699","article-title":"Human host factors required for influenza virus replication","volume":"463","author":"Konig","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.08.008_bib0650","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","article-title":"Global analysis of host\u2013pathogen interactions that regulate early-stage HIV-1 replication","volume":"135","author":"Konig","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.08.008_bib0655","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1152725","article-title":"Identification of host proteins required for HIV infection through a functional genomic screen","volume":"319","author":"Brass","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0660","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0665","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature08760","article-title":"Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication","volume":"463","author":"Karlas","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0670","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07151","article-title":"Drosophila RNAi screen identifies host genes important for influenza virus replication","volume":"454","author":"Hao","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0675","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2009.12.018","article-title":"A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection","volume":"139","author":"Shapira","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.08.008_bib0680","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1101\/gad.1267905","article-title":"Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition","volume":"19","author":"Cherry","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.coviro.2015.08.008_bib0685","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2008.10.007","article-title":"Knockdown screens to knockout HIV-1","volume":"135","author":"Goff","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.08.008_bib0690","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature07207","article-title":"RNA interference screen for human genes associated with West Nile virus infection","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.08.008_bib0695","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1073\/pnas.0907439106","article-title":"A genome-wide genetic screen for host factors required for hepatitis C virus propagation","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.08.008_bib0700","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.chom.2008.10.004","article-title":"Genome-scale RNAi screen for host factors required for HIV replication","volume":"4","author":"Zhou","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0705","doi-asserted-by":"crossref","first-page":"18235","DOI":"10.1073\/pnas.0705856104","article-title":"An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis","volume":"104","author":"Naito","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0710","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.virol.2009.02.046","article-title":"The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza","volume":"387","author":"Sui","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.08.008_bib0715","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/rmv.575","article-title":"Host factors for replication and transcription of the influenza virus genome","volume":"18","author":"Nagata","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0720","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1128\/JVI.79.9.5812-5818.2005","article-title":"Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II","volume":"79","author":"Engelhardt","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0725","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1128\/JVI.01565-06","article-title":"Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex","volume":"80","author":"Deng","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0730","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1128\/JVI.75.18.8597-8604.2001","article-title":"PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators","volume":"75","author":"Huarte","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0735","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/pmic.200700508","article-title":"Analysis of the interaction of influenza virus polymerase complex with human cell factors","volume":"8","author":"Jorba","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.coviro.2015.08.008_bib0740","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1038\/sj.emboj.7601881","article-title":"De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM","volume":"26","author":"Kawaguchi","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2015.08.008_bib0745","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/JVI.75.4.1899-1908.2001","article-title":"Cellular splicing factor RAF-2p48\/NPI-5\/BAT1\/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis","volume":"75","author":"Momose","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0750","doi-asserted-by":"crossref","first-page":"45306","DOI":"10.1074\/jbc.M206822200","article-title":"Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis","volume":"277","author":"Momose","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.08.008_bib0755","doi-asserted-by":"crossref","first-page":"e3904","DOI":"10.1371\/journal.pone.0003904","article-title":"The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication","volume":"3","author":"Resa-Infante","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2015.08.008_bib0760","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"Hale","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0765","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1128\/JVI.02651-10","article-title":"Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network","volume":"85","author":"Tafforeau","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0770","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/pr060432u","article-title":"Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches","volume":"6","author":"Mayer","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0775","doi-asserted-by":"crossref","first-page":"e1000085","DOI":"10.1371\/journal.ppat.1000085","article-title":"Cellular proteins in influenza virus particles","volume":"4","author":"Shaw","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0780","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1038\/ncomms5816","article-title":"Conserved and host-specific features of influenza virion architecture","volume":"5","author":"Hutchinson","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0785","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","article-title":"Influenza virus-host interactome screen as a platform for antiviral drug development","volume":"16","author":"Watanabe","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.08.008_bib0790","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","article-title":"IFITM3 restricts the morbidity and mortality associated with influenza","volume":"484","author":"Everitt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0795","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0800","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1039\/c2mb05416g","article-title":"Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery","volume":"8","author":"de Chassey","year":"2012","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.coviro.2015.08.008_bib0805","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2010.05.008","article-title":"Cellular networks involved in the influenza virus life cycle","volume":"7","author":"Watanabe","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.08.008_bib0810","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/rmv.703","article-title":"The host interactome of influenza virus presents new potential targets for antiviral drugs","volume":"21","author":"Shaw","year":"2011","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0815","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.micinf.2011.01.012","article-title":"Uncovering the global host cell requirements for influenza virus replication via RNAi screening","volume":"13","author":"Stertz","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.coviro.2015.08.008_sbref0820","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1752-0509-7-97","article-title":"A comprehensive map of the influenza A virus replication cycle","volume":"7","author":"Matsuoka","year":"2013","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0825","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nature10011","article-title":"Controllability of complex networks","volume":"473","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.08.008_bib0830","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1752-0509-4-161","article-title":"Confidence from uncertainty\u2014a multi-target drug screening method from robust control theory","volume":"4","author":"Luni","year":"2010","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0835","doi-asserted-by":"crossref","first-page":"e1001329","DOI":"10.1371\/journal.ppat.1001329","article-title":"Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway","volume":"7","author":"de Vries","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.08.008_bib0840","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1476-5381.2011.01346.x","article-title":"The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections","volume":"164","author":"Muller","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0845","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.virol.2008.04.040","article-title":"Hsp90 inhibitors reduce influenza virus replication in cell culture","volume":"377","author":"Chase","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.08.008_bib0850","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1099\/vir.0.82483-0","article-title":"Effect of the phosphatidylinositol 3-kinase\/Akt pathway on influenza A virus propagation","volume":"88","author":"Shin","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0855","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.1500","article-title":"Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy","volume":"26","author":"Munger","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coviro.2015.08.008_bib0860","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.01048-10","article-title":"Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step","volume":"84","author":"Widjaja","year":"2010","journal-title":"J Virol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:59:06Z","timestamp":1761818346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625715001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":86,"alternative-id":["S1879625715001273"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2015.08.008","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza virus\u2013host interactomes as a basis for antiviral drug development","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}